Stocks to Watch Today, September 7, 2026: Brigade Enterprises, Lupin, Jayaswal Neco Industries, DCX Systems and Rail Vikas Nigam
- TCS announces massive ₹70,000 crore AI campus investment in Telangana
- Rail Vikas Nigam wins ₹404 crore railway contract and secures loan
- Jayaswal Neco drops nearly 10% after paying BSE fine for delayed filings
- Pharma sector faces scrutiny as Cohance and Indoco receive FDA observations
- Brigade Enterprises expands into Coimbatore with new residential project

*this image is generated using AI for illustrative purposes only.
Infrastructure and tech capex drive sentiment today, with TCS unveiling a massive ₹70,000 crore AI campus in Telangana. Meanwhile, Jayaswal Neco tumbles 9.8% following a regulatory penalty. Here's what's moving.
Brigade Enterprises
- Expansion: Enters Coimbatore with a ₹600 crore residential JDA project spanning 5.4 acres in Saravanampatti. Stock closed at ₹696.10 in the previous session, down 2.27%.
- Corporate Action: Incorporated two wholly owned subsidiaries, Celebrations Property and Tetrarch Estates, each with ₹10 crore authorised capital to ring-fence development projects.
- Retail: Opened a six-screen PVR INOX at Arcadia, Utopia, marking its fourth multiplex in Bengaluru.
Lupin
- Regulatory: Received US FDA approval for Modafinil Tablets, expanding its wakefulness-promoting agent portfolio for narcolepsy treatment. Stock closed at ₹2110.00 in the previous session, down 1.03%.
- Rating: Awarded a Crisil ESG rating of 69 for FY26, placing the firm in the 'Strong' category with a Core ESG rating of 65.
Jayaswal Neco Industries
- Regulatory: Paid a ₹75.59 lakh fine to BSE under protest for a 20-day delay in submitting Q2FY16 shareholding patterns. Stock closed at ₹89.04 in the previous session, down 9.77%.
- Clarification: Clarified that Datasel SRL is neither a subsidiary nor an associate company, stating no financial impact from the entity.
DCX Systems
- Technology: Advances indigenous radar and EW tech through joint ventures with ELTX and NIART Systems to build domestic defence electronics competencies. Stock closed at ₹168.83 in the previous session, down 0.44%.
- Corporate Action: Scheduled 15th AGM for September 28 to adopt FY26 financials and seek reappointment of Gopinath Vedaprakash as director.
Rail Vikas Nigam
- Order Book: Emerged as L1 for a ₹404.88 crore East Coast Railway project involving roadbed construction and electrification over 30 months. Stock closed at ₹212.49 in the previous session, up 1.52%.
- Fund Raise: Secured a ₹903 crore loan from SJVN Thermal for the Buxar Power Project in Bihar.
- Management: Accepted resignation of Ajit Singh as Pr. Executive Director due to superannuation.
Cohance Lifesciences
- Regulatory: Received four observations on FDA Form 483 following an inspection at its formulation plant. Stock closed at ₹456.60 in the previous session, down 0.92%.
- Compliance: Plans to initiate corrective actions and respond timely to the USFDA observations, which do not constitute final regulatory action.
Indoco Remedies
- Regulatory: Goa Plant II received seven USFDA observations (Form 483) following a regulatory inspection of its sterile manufacturing unit. Stock closed at ₹262.51 in the previous session, down 3.69%.
- Promoter Activity: Promoters Aditi M. Panandikar and Madhura Suresh Kare bought 4,000 shares total via open market on September 1.
Tata Consultancy Services
- Capex: Subsidiary HyperVault secures 264 acres in Hyderabad for a 1GW AI data center campus with up to ₹70,000 crore investment. Stock closed at ₹2304.00 in the previous session, down 0.69%.
- Deal: Selected as strategic partner by Metro AG for AI-driven IT transformation to streamline centralised technology applications.
How will TCS's ₹70,000 crore AI campus investment impact the local real estate and infrastructure supply chain in Telangana over the next 3-5 years?
What are the potential long-term revenue risks for Lupin and Cohance Lifesciences if their USFDA compliance issues persist or lead to stricter regulatory scrutiny?
Could Jayaswal Neco's regulatory penalty and delayed disclosures signal deeper governance issues that might deter institutional investors in the medium term?
























